Guidant Heart Failure ICD Trials Showing Significant Decrease In Hospital Stay
This article was originally published in The Gray Sheet
Executive Summary
Implantable cardioverter defibrillators (ICDs) are cost-effective in the long run for treating patients with congestive heart failure (CHF), said Guidant VP and Treasurer Todd McKinney asserted at a Dec. 14 ING-Barings health care conference in New York City.